z-logo
open-access-imgOpen Access
CD29 Enriches for Cytotoxic Human CD4+ T Cells
Author(s) -
Benoît P. Nicolet,
Aurélie Guislain,
Monika C. Wolkers
Publication year - 2021
Publication title -
the journal of immunology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.2100138
Subject(s) - cytotoxic t cell , cancer research , chemistry , medicine , biochemistry , in vitro
CD4 + T cells are key contributors in the induction of adaptive immune responses against pathogens. Even though CD4 + T cells are primarily classified as noncytotoxic helper T cells, it has become appreciated that a subset of CD4 + T cells is cytotoxic. However, tools to identify these cytotoxic CD4 + T cells are lacking. We recently showed that CD29 (integrin β1, ITGB1) expression on human CD8 + T cells enriches for the most potent cytotoxic T cells. In this study, we questioned whether CD29 expression also associates with cytotoxic CD4 + T cells. We show that human peripheral blood-derived CD29 hi CD4 + T cells display a cytotoxic gene expression profile, which closely resembles that of CD29 hi cytotoxic CD8 + T cells. This CD29 hi cytotoxic phenotype was observed ex vivo and was maintained in in vitro cultures. CD29 expression enriched for CD4 + T cells, which effectively produced the proinflammatory cytokines IFN-γ, IL-2, and TNF-α, and cytotoxic molecules. Lastly, CD29-expressing CD4 + T cells transduced with a MART1-specific TCR showed target cell killing in vitro. In conclusion, we demonstrate in this study that CD29 can be employed to enrich for cytotoxic human CD4 + T cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom